Antisense oligonucleotide-directed liver therapy: a new tool in the MASH armamentarium?

Paul N Brennan; John F Dillon

doi:10.1016/S0140-6736(25)01179-1

Antisense oligonucleotide-directed liver therapy: a new tool in the MASH armamentarium?

Paul N Brennan (Lead / Corresponding author)
, John F Dillon

MED Respiratory Medicine and Gastroenterology

Research output: Contribution to journal › Comment/debate › peer-review

73 Downloads (Pure)

Original language	English
Pages (from-to)	783-784
Number of pages	2
Journal	Lancet
Volume	406
Issue number	10505
Early online date	21 Aug 2025
DOIs	https://doi.org/10.1016/S0140-6736(25)01179-1
Publication status	Published - 23 Aug 2025

Access to Document

10.1016/S0140-6736(25)01179-1

Author Accepted ManuscriptAccepted author manuscript, 234 KBLicence: CC BY-NC-ND

Cite this

@article{c6faa233240d4b95af9972075e86bea0,

title = "Antisense oligonucleotide-directed liver therapy: a new tool in the MASH armamentarium?",

author = "Brennan, \{Paul N\} and Dillon, \{John F\}",

note = "Crown Copyright {\textcopyright} 2025 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.",

year = "2025",

month = aug,

day = "23",

doi = "10.1016/S0140-6736(25)01179-1",

language = "English",

volume = "406",

pages = "783--784",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "10505",

}

TY - JOUR

T1 - Antisense oligonucleotide-directed liver therapy

T2 - a new tool in the MASH armamentarium?

AU - Brennan, Paul N

AU - Dillon, John F

PY - 2025/8/23

Y1 - 2025/8/23

UR - https://www.scopus.com/pages/publications/105013543462

U2 - 10.1016/S0140-6736(25)01179-1

DO - 10.1016/S0140-6736(25)01179-1

M3 - Comment/debate

C2 - 40849125

SN - 0140-6736

VL - 406

SP - 783

EP - 784

JO - Lancet

JF - Lancet

IS - 10505

ER -

Antisense oligonucleotide-directed liver therapy: a new tool in the MASH armamentarium?

Access to Document

Other files and links

Cite this